Ezchek/Hba Blood Collection Kit

FDA 510(k) K971919 · Flexsite Diagnostics, Inc.

Substantially Equivalent

510(k) numberK971919

Submission

Device name
Ezchek/Hba Blood Collection Kit
Applicant
Flexsite Diagnostics, Inc.
Washington, DC, US
Received
May 23, 1997
Decision date
September 5, 1997
Decision
Substantially Equivalent (SESE)
Type
Traditional 510(k)
Summary
510(k) summary available from FDA

Official FDA 510(k) record

Device classification

Product code
LCP – Assay, Glycosylated Hemoglobin
Device class
Class II (moderate risk)
Regulation
21 CFR 864.7470
Specialty
Hematology

Other 510(k)s with product code LCP

510(k)DeviceApplicantDecision
K221326Nova Allegro HbA1c Assay, Nova Allegro AnalyzerLCP · Dual Track Nova Biomedical Corporation11/22/2024SE
K231465Q-Pad Test SystemLCP · Traditional Qurasense12/06/2023SE
K214117Afinion™ HbA1c, Afinion™ 2 and Alere Afinion™ AS100 AnalyzerLCP · Dual Track Abbott Diagnostics Technologies AS09/27/2023SE
K192987Aina HbA1c Monitoring System 2LCP · Traditional Jana Care, Inc.03/26/2020SE
K192369PixoTest POCT System - PixoTest POCT Analyzer and PixoTest A1c Test KitLCP · Traditional Ixensor Co, Ltd.10/29/2019SE
K183230OneDraw A1C Test SystemLCP · Traditional Drawbridge Health, Inc.08/15/2019SE
K181915PixoTest POCT System - PixoTest POCT Analyzer and PixoTest A1c Test KitLCP · Traditional Ixensor Co, Ltd.04/12/2019SE
K180509Quo-Test A1c SystemLCP · Dual Track Ekf-Diagnostic GmbH02/16/2019SE
K173127skyla Hi Hemoglobin A1c System (skyla Hi Analyzer and skyla Hi Hemoglobin A 1 c Reagent…LCP · Traditional Skyla Corporation H.S.P.B09/25/2018SE
K170623ACE Hemoglobin A1c (HbA1c) ReagentLCP · Traditional Alfa Wassermann Diagnostic Technologies, LLC02/27/2018SE

More from Alfa Wassermann Diagnostic Technologies, LLC

510(k)DeviceDecision
K001810Urisite Urine Collection Kit for Microalbumin/Creatinine TestingJIR · Traditional 08/14/2000SE

Questions and answers

When was Ezchek/Hba Blood Collection Kit cleared by the FDA?

Ezchek/Hba Blood Collection Kit (K971919) received a 510(k) decision of Substantially Equivalent on September 5, 1997, 105 days after the submission was received.

What is the product code of K971919?

The FDA product code is LCP – Assay, Glycosylated Hemoglobin, a Class II (moderate risk) device regulated under 21 CFR 864.7470.